Ischemic Stroke in Acute Decompensated Heart Failure: From the KCHF Registry.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
02 11 2021
Historique:
pubmed: 26 10 2021
medline: 4 3 2022
entrez: 25 10 2021
Statut: ppublish

Résumé

Background Heart failure (HF) is a known risk factor for ischemic stroke, but data regarding ischemic stroke during hospitalization for acute decompensated HF (ADHF) are limited. Methods and Results We analyzed the data from a multicenter registry (Kyoto Congestive Heart Failure [KCHF] Registry) that enrolled 4056 consecutive patients with ADHF in Japan (mean age, 78 years; men, 2238 patients [55%]; acute coronary syndrome [ACS], 239 patients [5.9%]). We investigated the incidence and predictors of ischemic stroke during hospitalization for ADHF. During the hospitalization, 63 patients (1.6%) developed ischemic stroke. The median interval from admission to the onset of ischemic stroke was 7 [interquartile range: 2-14] days, and the most common underlying cause was cardioembolism (64%). Men (OR, 1.87; 95%CI, 1.11-3.24), ACS (OR, 2.31; 95%CI, 1.01-4.93), absence of prior HF hospitalization (OR, 2.21; 95%CI, 1.24-4.21), and high B-type natriuretic peptide (BNP)/N-terminal proBNP (NT-proBNP) levels (above the median) at admission (OR, 3.15; 95%CI, 1.84-5.60) were independently associated with ischemic stroke. In patients without ACS, the independent risk factors for ischemic stroke were fully consistent with those in the main analysis. Higher quartiles of BNP/NT-proBNP levels were significantly associated with higher incidence of ischemic stroke (

Identifiants

pubmed: 34689603
doi: 10.1161/JAHA.121.022525
pmc: PMC8751829
doi:

Substances chimiques

Biomarkers 0
Peptide Fragments 0
Natriuretic Peptide, Brain 114471-18-0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e022525

Références

J Heart Valve Dis. 1993 Jan;2(1):25-34; discussion 35-6
pubmed: 8269108
Int J Cardiol. 2020 Jan 1;298:93-97
pubmed: 31272739
BMJ Open. 2012 Jul 07;2(4):
pubmed: 22773537
Circ Rep. 2019 Oct 26;1(11):517-524
pubmed: 33693094
J Am Coll Cardiol. 2007 Dec 18;50(25):2357-68
pubmed: 18154959
Stroke. 2014 May;45(5):1324-30
pubmed: 24692479
J Am Heart Assoc. 2016 Jul 13;5(7):
pubmed: 27413043
Stroke. 2002 Apr;33(4):1005-10
pubmed: 11935052
Circ Heart Fail. 2011 May;4(3):361-8
pubmed: 21586736
Circ J. 2018 Oct 25;82(11):2811-2819
pubmed: 30259898
J Am Coll Cardiol. 2013 Jun 4;61(22):2274-84
pubmed: 23563134
Lancet Neurol. 2008 Oct;7(10):915-26
pubmed: 18722812
Eur J Epidemiol. 2010 Nov;25(11):807-12
pubmed: 21061046
Chest. 2010 Jul;138(1):47-51
pubmed: 20154074
N Engl J Med. 2012 May 17;366(20):1859-69
pubmed: 22551105
Circulation. 2009 Mar 31;119(12):1616-24
pubmed: 19289640
Stroke. 2011 Oct;42(10):2977-82
pubmed: 21903953
ESC Heart Fail. 2017 Aug;4(3):216-223
pubmed: 28772047
J Am Coll Cardiol. 1999 Apr;33(5):1424-6
pubmed: 10193748
Stroke. 2017 May;48(5):1161-1168
pubmed: 28377383
N Engl J Med. 2015 Aug 27;373(9):823-33
pubmed: 26095867
Eur Heart J. 2019 Nov 21;40(44):3593-3602
pubmed: 31461239
Circ J. 2018 Apr 25;82(5):1327-1335
pubmed: 29526914
JACC Heart Fail. 2021 Apr;9(4):243-253
pubmed: 33714744
Heart Vessels. 2016 Jul;31(7):1154-61
pubmed: 26219729
N Engl J Med. 2004 Feb 12;350(7):655-63
pubmed: 14960742
Clin Cardiol. 2019 Feb;42(2):277-284
pubmed: 30578576
Drugs. 2003;63(6):565-76
pubmed: 12656654
Circulation. 2015 Apr 28;131(17):1486-94; discussion 1494
pubmed: 25810334
Lancet Neurol. 2010 Oct;9(10):1008-17
pubmed: 20864053
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
JAMA Cardiol. 2019 Jun 1;4(6):515-523
pubmed: 31017637

Auteurs

Moritake Iguchi (M)

Department of Cardiology National Hospital Organization Kyoto Medical Center Kyoto Japan.

Takao Kato (T)

Department of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.

Hidenori Yaku (H)

Department of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.

Takeshi Morimoto (T)

Department of Clinical Epidemiology Hyogo College of Medicine Hyogo Japan.

Yasutaka Inuzuka (Y)

Department of Cardiovascular Medicine Shiga General Hospital Shiga Japan.

Yodo Tamaki (Y)

Division of Cardiology Tenri Hospital Nara Japan.

Neiko Ozasa (N)

Department of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.

Erika Yamamoto (E)

Department of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.

Yusuke Yoshikawa (Y)

Department of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.

Takeshi Kitai (T)

Department of Cardiovascular Medicine National Cerebral and Cardiovascular Center Osaka Japan.
Department of Rehabilitation Kobe City Medical Center General Hospital Hyogo Japan.

Yasuhiro Hamatani (Y)

Department of Cardiology National Hospital Organization Kyoto Medical Center Kyoto Japan.

Yugo Yamashita (Y)

Department of Cardiology National Hospital Organization Kyoto Medical Center Kyoto Japan.
Department of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.

Nobutoyo Masunaga (N)

Department of Cardiology National Hospital Organization Kyoto Medical Center Kyoto Japan.

Hisashi Ogawa (H)

Department of Cardiology National Hospital Organization Kyoto Medical Center Kyoto Japan.

Mitsuru Ishii (M)

Department of Cardiology National Hospital Organization Kyoto Medical Center Kyoto Japan.

Yoshimori An (Y)

Department of Cardiology National Hospital Organization Kyoto Medical Center Kyoto Japan.

Ryoji Taniguchi (R)

Department of Cardiology Hyogo Prefectural Amagasaki General Medical Center Hyogo Japan.

Masashi Kato (M)

Mitsubishi Kyoto Hospital Kyoto Japan.

Mamoru Takahashi (M)

Shimabara Hospital Kyoto Japan.

Toshikazu Jinnai (T)

Japanese Red Cross Otsu Hospital Shiga Japan.

Tomoyuki Ikeda (T)

Hikone Municipal Hospital Shiga Japan.

Kazuya Nagao (K)

Osaka Red Cross Hospital Osaka Japan.

Takafumi Kawai (T)

Kishiwada City Hospital Osaka Japan.

Akihiro Komasa (A)

Kansai Electric Power Hospital Osaka Japan.

Ryusuke Nishikawa (R)

Shizuoka General Hospital Shizuoka Japan.

Yuichi Kawase (Y)

Kurashiki Central Hospital Okayama Japan.

Takashi Morinaga (T)

Kokura Memorial Hospital Fukuoka Japan.

Mitsunori Kawato (M)

Nishikobe Medical Center Hyogo Japan.

Yuta Seko (Y)

Kitano Hospital Osaka Japan.

Mamoru Toyofuku (M)

Japanese Red Cross Wakayama Medical Center Wakayama Japan.

Yutaka Furukawa (Y)

Department of Cardiovascular Medicine Kobe City Medical Center General Hospital Hyogo Japan.

Kenji Ando (K)

Kokura Memorial Hospital Fukuoka Japan.

Kazushige Kadota (K)

Kurashiki Central Hospital Okayama Japan.

Mitsuru Abe (M)

Department of Cardiology National Hospital Organization Kyoto Medical Center Kyoto Japan.

Masaharu Akao (M)

Department of Cardiology National Hospital Organization Kyoto Medical Center Kyoto Japan.

Yukihito Sato (Y)

Department of Cardiology Hyogo Prefectural Amagasaki General Medical Center Hyogo Japan.

Koichiro Kuwahara (K)

Department of Cardiovascular Medicine Shinshu University Graduate School of Medicine Matsumoto Japan.

Takeshi Kimura (T)

Department of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH